TARDBP and Cognitive impairment: Thalamic involvement is considered an early biomarker of ALS, contributing to both motor and cognitive deficits in sporadic cases (61–64), and is described as an early event, i.e., stage 2 in the Braak staging system of TDP-43 pathology spread (65, 66).